 GAINESVILLE, Fla.--BUSINESS WIRE--Cyclo Therapeutics, Inc. Nasdaq: CYTH Cyclo Therapeutics or the Company, a clinical stage biotechnology company dedicated to developing life-changing medicines through science and innovation for patients and families suffering from disease, today announced that N. Scott Fine, CEO of Cyclo Therapeutics will present at the Inaugural Emerging Growth Virtual Conference presented by M-Vest LLC and Maxim Group LLC. The conference will take place virtually o 